A higher frequency of IL‐10‐producing B cells in Hepatitis B virus‐associated membranous nephropathy. (April 2016)
- Record Type:
- Journal Article
- Title:
- A higher frequency of IL‐10‐producing B cells in Hepatitis B virus‐associated membranous nephropathy. (April 2016)
- Main Title:
- A higher frequency of IL‐10‐producing B cells in Hepatitis B virus‐associated membranous nephropathy
- Authors:
- Liu, Yong
Wang, Haifeng
Hu, Xintong
Qu, Zhihui
Zhang, Huimao
Crew, Rebecca
Ayana, Desalegn Admassu
Li, Man
Qiu, Jinpeng
Jiang, Yanfang - Abstract:
- Summary: The purpose of this study is to elucidate the potential role of interleukin (IL)‐10 + regulatory B cells and other B cell subsets in the development of hepatitis B virus‐associated membranous nephropathy (HBV‐MN). A total of 14 patients with new onset HBV‐MN, 12 individuals with immune‐tolerant HBV infection (HBV‐IT), and 12 healthy controls (HC) were examined for the percentages of CD38 +, CD86 +, CD27 +, CD95 + and IL‐10 + B cells by flow cytometry. Serum IL‐10 concentration was examined by enzyme‐linked immunosorbent assay (ELISA). The percentages of CD38 + CD19 +, CD86 + CD19 +, CD38 + CD86 + CD19 +, and CD95 + CD19 + B cells were significantly higher in HBV‐MN patients than the HBV‐IT and HC. The percentages of CD5 + CD19 +, IL‐10 + CD19 + B cells and serum IL‐10 level in HBV‐MN patients were significantly higher than the HC, and lower than the HBV‐IT. Percentages of CD38 + CD19 +, and CD86 + CD19 + B cells were reduced after treatment, while the percentages of CD5 + CD1d + CD19 +, CD5 + CD1d + IL‐10 + CD19 +, and IL‐10 + CD19 + B cells were increased. The 24 h urinary protein concentration was positively correlated with the percentage of CD38 + CD19 +, and negatively correlated with the percentage of IL‐10 + CD19 + B cells and serum IL‐10 level. Similarly, the value of eGFR was negatively correlated with the percentage of CD38 + CD19 +, and positively correlated with the percentage of IL‐10 + CD19 + B cells and serum IL‐10 level. Serum IL‐10 level and theSummary: The purpose of this study is to elucidate the potential role of interleukin (IL)‐10 + regulatory B cells and other B cell subsets in the development of hepatitis B virus‐associated membranous nephropathy (HBV‐MN). A total of 14 patients with new onset HBV‐MN, 12 individuals with immune‐tolerant HBV infection (HBV‐IT), and 12 healthy controls (HC) were examined for the percentages of CD38 +, CD86 +, CD27 +, CD95 + and IL‐10 + B cells by flow cytometry. Serum IL‐10 concentration was examined by enzyme‐linked immunosorbent assay (ELISA). The percentages of CD38 + CD19 +, CD86 + CD19 +, CD38 + CD86 + CD19 +, and CD95 + CD19 + B cells were significantly higher in HBV‐MN patients than the HBV‐IT and HC. The percentages of CD5 + CD19 +, IL‐10 + CD19 + B cells and serum IL‐10 level in HBV‐MN patients were significantly higher than the HC, and lower than the HBV‐IT. Percentages of CD38 + CD19 +, and CD86 + CD19 + B cells were reduced after treatment, while the percentages of CD5 + CD1d + CD19 +, CD5 + CD1d + IL‐10 + CD19 +, and IL‐10 + CD19 + B cells were increased. The 24 h urinary protein concentration was positively correlated with the percentage of CD38 + CD19 +, and negatively correlated with the percentage of IL‐10 + CD19 + B cells and serum IL‐10 level. Similarly, the value of eGFR was negatively correlated with the percentage of CD38 + CD19 +, and positively correlated with the percentage of IL‐10 + CD19 + B cells and serum IL‐10 level. Serum IL‐10 level and the percentage of IL‐10 + CD19 + were negatively correlated with the percentages of CD38 + CD19 +, and CD86 + CD19 + B cells. These results suggest that CD86 + CD19 +, CD38 + CD86 + CD19 +, CD95 + CD19 +, and especially CD38 + CD19 + and IL‐10 + CD19 + cells may participate in the pathogenesis of HBV‐MN. … (more)
- Is Part Of:
- Clinical and experimental pharmacology and physiology. Volume 43:Number 4(2016:Apr.)
- Journal:
- Clinical and experimental pharmacology and physiology
- Issue:
- Volume 43:Number 4(2016:Apr.)
- Issue Display:
- Volume 43, Issue 4 (2016)
- Year:
- 2016
- Volume:
- 43
- Issue:
- 4
- Issue Sort Value:
- 2016-0043-0004-0000
- Page Start:
- 417
- Page End:
- 427
- Publication Date:
- 2016-04
- Subjects:
- breg cell -- HBV‐MN -- IL‐10 -- plasma cell
Clinical pharmacology -- Periodicals
Pharmacology, Experimental -- Periodicals
Physiology, Experimental -- Periodicals
Physiology, Pathological -- Periodicals
615.1 - Journal URLs:
- http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=cep ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/1440-1681.12552 ↗
- Languages:
- English
- ISSNs:
- 0305-1870
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.252000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 1334.xml